Vanguard Group Inc Tg Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 15,809,317 shares of TGTX stock, worth $502 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,809,317
Previous 15,604,512 1.31%
Holding current value
$502 Million
Previous $615 Million 7.53%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$33.37 - $45.51 $6.83 Million - $9.32 Million
204,805 Added 1.31%
15,809,317 $569 Million
Q1 2025

May 09, 2025
BUY
$27.67 - $42.99 $222,245 - $345,295
8,032 Added 0.05%
15,604,512 $615 Million
Q4 2024

Feb 11, 2025
BUY
$21.31 - $35.09 $4.46 Million - $7.34 Million
209,190 Added 1.36%
15,596,480 $469 Million
Q3 2024

Nov 13, 2024
BUY
$17.21 - $25.28 $29.2 Million - $42.9 Million
1,695,600 Added 12.38%
15,387,290 $360 Million
Q2 2024

Aug 13, 2024
BUY
$13.32 - $19.19 $2.06 Million - $2.97 Million
154,858 Added 1.14%
13,691,690 $244 Million
Q1 2024

May 10, 2024
SELL
$13.02 - $21.3 $1.75 Million - $2.86 Million
-134,112 Reduced 0.98%
13,536,832 $206 Million
Q4 2023

Feb 14, 2024
BUY
$6.68 - $18.81 $1.33 Million - $3.76 Million
199,770 Added 1.48%
13,670,944 $233 Million
Q3 2023

Nov 14, 2023
BUY
$8.36 - $26.5 $134,378 - $425,961
16,074 Added 0.12%
13,471,174 $113 Million
Q2 2023

Aug 14, 2023
BUY
$15.48 - $35.0 $1.17 Million - $2.65 Million
75,593 Added 0.56%
13,455,100 $334 Million
Q1 2023

May 15, 2023
SELL
$10.23 - $19.34 $21.7 Million - $41.1 Million
-2,123,257 Reduced 13.7%
13,379,507 $201 Million
Q4 2022

Feb 10, 2023
BUY
$5.01 - $11.83 $3.79 Million - $8.95 Million
756,372 Added 5.13%
15,502,764 $183 Million
Q3 2022

Nov 14, 2022
BUY
$4.57 - $8.4 $7.89 Million - $14.5 Million
1,725,560 Added 13.25%
14,746,392 $87.3 Million
Q2 2022

Aug 12, 2022
BUY
$3.74 - $10.66 $3.33 Million - $9.49 Million
889,869 Added 7.34%
13,020,832 $55.3 Million
Q1 2022

May 13, 2022
BUY
$7.81 - $20.45 $308,698 - $808,306
39,526 Added 0.33%
12,130,963 $115 Million
Q4 2021

Feb 14, 2022
BUY
$15.2 - $35.51 $897,727 - $2.1 Million
59,061 Added 0.49%
12,091,437 $230 Million
Q3 2021

Nov 12, 2021
BUY
$21.78 - $40.45 $6.69 Million - $12.4 Million
307,032 Added 2.62%
12,032,376 $400 Million
Q2 2021

Aug 13, 2021
BUY
$32.5 - $48.96 $381 Million - $574 Million
11,725,344 New
11,725,344 $455 Million

Others Institutions Holding TGTX

# of Institutions
406
Shares Held
92.5M
Call Options Held
2.28M
Put Options Held
1.78M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.61B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email